Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia 4Neoplasm, Residual 2Lymphoma, Large-Cell, Anaplastic 2Burkitt Lymphoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Disease 1

Interventions

Vindesine 1Vincristine 1Rituximab 1Radiation 1Prednisolone 1Methotrexate 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Doxorubicin 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mediastinal Neoplasms × Vindesine × Lymphoid × Clear all
NCT00199082 2022-08-19

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Goethe University

Phase 4 Completed
650 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Mediastinal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡